IN THE HEALTHY LUNG, THE ALVEOLAR epithelium acts as a barrier to fluid leak and regulates ion transport to promote fluid absorption from the alveolar space (17, 26, 33) . Conversely, insults that compromise the alveolar barrier promote the accumulation of fluid within the air space, leading to acute lung injury. Importantly, the severity of injury is directly related to the level of lung epithelial barrier dysfunction (49) . Epithelial barrier function is critically dependent on tight junctions, structures localized to sites of cell-cell contact. Tight junctions control fluid diffusion between cells by creating a barrier that specifically regulates paracellular permeability to ions and small molecules.
Claudins, a large family of tetraspan transmembrane proteins, form the structural basis for regulated tight junction permeability (2, 3, 30) . Overall paracellular permeability is determined by the pattern of claudin expression in a particular epithelial cell type. Of the 24 claudin family proteins, Ͼ6, including claudin (Cldn)-1, Cldn-3, Cldn-4, Cldn-5, Cldn-7, and Cldn-18, have been found to be expressed by alveolar epithelial cells (8, 14, 29, 51) . Of these, type II alveolar epithelial cells are enriched for Cldn-3; type I cells have low Cldn-3 protein content (24, 31, 48) . In contrast, Cldn-4, which is closely homologous to Cldn-3, is expressed by type I and type II cells. While patterns of claudin expression in the alveolar epithelium are emerging, our understanding of the functional roles for each of the specific claudins remains incomplete.
Recently, Wray et al. (51) determined that, in the lung, Cldn-4 is upregulated in response to ventilator-induced lung injury. The finding of a specific increase in Cldn-4 expression allowed the investigators to use a peptide fragment (CPE BD ) derived from Clostridium perfringens enterotoxin (CPE) as a probe for Cldn-4 function (35) . CPE BD administered in vivo significantly decreased Cldn-4 content of the lung. Functionally, CPE BD treatment dramatically increased pulmonary edema and bulk alveolar protein permeability (leak) in response to severe ventilator-induced lung injury, underscoring a role for Cldn-4 in protecting the lung from mechanical injury to tight junctions (51) . Cultured alveolar epithelial cells treated with CPE BD also exhibited a decrease in Cldn-4 and a concomitant decrease in transepithelial resistance (TER). In addition, a small interfering RNA-mediated reduction in Cldn-4 led to a similar decrease in TER, suggesting that the changes in lung alveolar epithelium after treatment with CPE BD are specific to . Consistent with these observations, alveolar Cldn-4 is also decreased in a cecal ligation-and-puncture model of sepsis, which could also exacerbate lung function due to a decrease in alveolar epithelial barrier function (9) .
Although CPE BD has considerable utility as a tool for manipulating claudins in vivo, one drawback is that CPE BD binds strongly to Cldn-3 and Cldn-4, both of which are present in the alveolus (28) . Indeed, Wray et al. (51) showed that, in lungs treated with CPE BD , Cldn-3 and Cldn-4 were decreased, and a similar result was obtained in cultured epithelial cells. Since the first extracellular loop domains of Cldn-3 and Cldn-4 are 94% identical at the amino acid level (15) , these two claudins would be expected to serve similar roles in regulating paracellular ion permeability. However, this possibility has not been directly examined in the context of the alveolar epithelium.
To identify roles for Cldn-3 and Cldn-4 in regulating alveolar epithelial barrier function, we generated adenovector expression constructs to transduce primary alveolar epithelial cells to increase expression of Cldn-3 or Cldn-4. Increasing Cldn-4 expression augmented alveolar epithelial TER; however, increasing Cldn-3 expression had the opposite effect.
Moreover, increasing Cldn-3 increased short-circuit current (I sc ) and paracellular permeability to aqueous molecules. These results indicate that Cldn-3 and Cldn-4 have distinct roles in regulating alveolar epithelial barrier function, despite a nearly identical amino acid sequence in the extracellular loop domain responsible for determining the charge specificity of their paracellular permeability.
MATERIALS AND METHODS
Isolation and culture of rat type II alveolar epithelial cells. Animal protocols were reviewed and approved by the Institutional Animal Care and Use Committee of Emory University. Sprague-Dawley rat type II alveolar epithelial cells were isolated from lungs lavaged and perfused with elastase using the method of Dobbs et al. (16) with modifications (1). Preparations routinely contained Ͼ90 -95% type II alveolar epithelial cells. Freshly isolated cells were cultured in Earle's MEM (Life Technologies, Rockville, MD) containing 10% FBS, 25 g/ml gentamicin, and 0.25 g/ml amphotericin B (Life Technologies) in Transwell supports coated with rat tail type I collagen (Roche Diagnostics, Mannheim, Germany) at 7.5 ϫ 10 5 cells/ml, as previously described (29) .
Adenoviral vector production and transduction. NH 2-terminal, enhanced yellow fluorescent protein (YFP)-tagged Cldn-3 and Cldn-4 cDNAs were produced as previously described (15) , removed using KpnI and XbaI, and then ligated into pAdLox using standard molecular biological techniques. YFP-Cldn-3/AdLox, YFP-Cldn-4/AdLox, and YFP control vector were packaged and amplified by the National Heart, Lung, and Blood Institute Viral Vector Core at the University of Pittsburgh.
Alveolar epithelial cells cultured for 4 days on Transwell supports were incubated with adenovector constructs added to the apical and basal sides and then analyzed at day 6. Adenovector titers were adjusted to yield comparable levels of cell transduction and transgene protein expression.
Barrier function measurements. TER of cells in medium cultured on permeable supports was measured using an Ohmmeter (World Precision Instruments, Sarasota, FL), as previously described, with cells in Ringer buffer (150 mM NaCl, 2 mM CaCl 2, 1 mM MgCl2, 10 mM glucose, 10 mM HEPES, pH 7.4) (14, 48) . Ussing chamber measurements were performed as previously described (29) with a VCC MC6/A&A II data analysis system (Physiologic Instruments, San Diego, CA). For measurement of I sc, cells on Snapwell inserts (Corning Life Sciences, Lowell, MA) were analyzed in Ringer buffer at 37°C. The ratio of Na permeability to Cl permeability (P Na/PCl) was calculated by the method of Hou et al. (21) from dilution potentials measured from monolayers with Ringer buffer on one side and Ringer buffer diluted 1:1 with Ringer solution in which 300 mM mannitol was substituted for NaCl to maintain osmotic neutrality on the other side. Apical-to-basal and basal-to-apical dilution potentials were measured. Paracellular dye permeability was assessed by simultaneous measurement of the diffusion of two different-sized fluorescent dyes across the cell monolayer, as previously described (48) . Briefly, the medium in the bottom chamber was replaced with PBS ϩ 0.675 mM CaCl 2 ϩ 0.2 mM MgCl2, and the medium in the top chamber was replaced with PBS ϩ Ca ϩ Mg containing 0.1 mg/ml calcein (0.66 kDa) and 1.0 mg/ml Texas Red dextran (10 kDa). The cells were further incubated at 37°C for 2 h. At varying intervals, the cell chamber was removed, and the amount of fluorophore that diffused into the lower chamber was measured using a multiwell plate fluorometer (PE Biosystems, Foster City, CA).
Immunofluorescence staining. Immunofluorescence staining was performed as previously described (14, 48) . Unless otherwise stated, antibodies were obtained from Invitrogen (Carlsbad, CA). After 6 days in culture, the cells were washed with PBS three times, fixed in 1:1 methanol-acetone for 2 min at room temperature, and washed three times with PBS, once with PBS ϩ 0.5% Triton X-100, and once with PBS ϩ 0.5% Triton X-100 ϩ 2% normal goat serum. Cells were incubated with primary anti-rabbit and/or anti-mouse antibodies in PBS ϩ 2% normal goat serum for 1 h, washed, incubated with Cy2-conjugated goat anti-rabbit IgG and Cy3-conjugated goat antimouse IgG (Jackson Immunoresearch) in PBS ϩ 2% normal goat serum, washed, and then mounted in Mowiol (Kuraray, Houston, TX) under a glass coverslip. Cells were imaged by phase-contrast and fluorescence microscopy using an Olympus IX70 microscope with a U-MWIBA filter pack (BP460 -490, DM505, BA515-550) or U-MNG filter pack (BP530 -550, DM570, BA590 -800ϩ) or by confocal immunofluorescence microscopy using an Olympus Fluoview FV1000 system. Minimum and maximum intensities were adjusted for images in parallel, so that the intensity scale remained linear to maximize dynamic range.
Biochemical analysis. After 6 days in culture, cells on permeable supports were harvested and lysed in 2ϫ sample buffer containing 50 mM DTT, resolved by SDS-PAGE, transferred to Immobilon membranes (Millipore, Billerica, MA), and blotted using primary antibodies and horseradish peroxidase-conjugated goat anti-rabbit IgG or goat anti-mouse IgG. Specific signals corresponding to a given protein were detected by immunoblot analysis using enhanced chemiluminescence reagent (GE Healthcare, Pittsburgh, PA) and quantified with an electrophoresis documentation and analysis system (Eastman Kodak, Rochester, NY). Normalization for protein content was done using parallel samples analyzed for actin. Tight junction protein content for samples from cells treated with YFP, YFP-Cldn-3, and YFP-Cldn-4 adenovectors was further normalized to values of samples from untreated cells. The amount of Cldn-4 relative to Cldn-3 was calculated using anti-Cldn-3, anti-Cldn-4, and anti-YFP immunoblots by the following formula:
For biochemical analysis of Triton X-100 extractability (14) , cells were harvested by scraping into 1 ml of PBS at 4°C, which was then brought to 0.5% Triton X-100 by addition of 25 l of 20% Triton X-100. The samples were incubated for 30 min at 4°C, centrifuged at 100,000 g for 30 min, and separated into Triton-soluble (supernatant) and -insoluble (pellet) fractions, which were equivalently diluted and then analyzed by SDS-PAGE and immunoblotting (see above). Statistical significance was calculated by t-test.
RESULTS
Two closely related claudins, Cldn-3 and Cldn-4, show significant differences in expression by alveolar epithelium. Cldn-3 is preferentially expressed by type II cells, whereas Cldn-4 is expressed throughout the alveolus and is upregulated in response to acute lung injury (8, 14, 29, 51) . Given the structural similarities between the two proteins, particularly in the extracellular loop domains, we sought to determine the effect of increased expression of Cldn-3 and Cldn-4 on alveolar epithelial cell barrier function. We developed adenoviral vectors that enabled transduction of primary alveolar epithelial cells with YFP-tagged Cldn-3 or Cldn-4. The YFP tag was added to the NH 2 terminus of each claudin, a modification previously shown not to interfere with proper claudin function, since it leaves the COOH terminus able to interact with tight junction scaffold proteins (e.g., ZO-1). Additionally, an NH 2 -terminal green fluorescent protein tag does not affect the ability of the extracellular loop domains to form functional tight junctions (32) .
To determine the effect of expression on alveolar epithelial function, primary type II alveolar epithelial cells were plated onto Transwell permeable supports to generate a model alveolar epithelial cell system (20) in which claudins found in type I cells are expressed (29, 48) . On day 4 of culture, cells were treated overnight with adenovectors to enable expression of YFP-Cldn-3, YFP-Cldn-4, or YFP control. Cells were further incubated for 2 days to achieve optimal transgene expression ( Fig. 1) and analyzed on day 6 of culture, similar to our previous analysis (29) . Under these conditions, expression of YFP-Cldn-3 relative to actin was 1.17 Ϯ 0.37 (n ϭ 5), and expression of YFP-Cldn-4 relative to actin was 0.86 Ϯ 0.07 (n ϭ 6). YFP-Cldn-3 and YFP-Cldn-4 were properly processed by alveolar epithelial cells, given that both localized to tight junctions at the plasma membrane, similar to untagged endogenous claudins (Fig. 1, A and B) . We found that transducing alveolar epithelial cells with YFP, YFP-Cldn-3, or YFP-Cldn-4 did not have a significant effect on the total protein level of endogenous Cldn-3 or Cldn-4 (Fig. 2) .
Using anti-YFP to normalize for YFP-Cldn-3 and YFPCldn-4, we were able to calculate the ratio of endogenous Cldn-4 to Cldn-3 expression (see MATERIALS AND METHODS). On the basis of these results, we found that model type I alveolar epithelial cells expressed about fourfold more Cldn-4 than Cldn-3 protein (Fig. 2D) . Model type I cells express low levels of endogenous Cldn-3, consistent with type I cells in vivo (31) . In fact, the amount of Cldn-3 expressed by type II cells was found by LaFemina and co-workers (31) to be ϳ16-fold higher than the amount of Cldn-3 expressed by type I cells.
Transducing cells with YFP-Cldn-3 increased total Cldn-3 expression by 6.8 Ϯ 3.7-fold (n ϭ 5) over baseline (Fig. 2D) . Thus the increase in total Cldn-3 in cells expressing YFPCldn-3 was consistent with the physiological difference in Cldn-3 expression between type II and type I cells. In YFPCldn-4-transduced cells, total Cldn-4 protein increased to 2.7 Ϯ 0.2-fold (n ϭ 6) higher than in nontransduced cells (Fig. 2D) . This level was ϳ50% higher than the increase in Cldn-4 protein observed by Wray and co-workers (51) in response to ventilator-induced lung injury, which caused Cldn-4 to increase to ϳ1.8-fold higher than baseline.
To examine the effect of increased Cldn-3 and Cldn-4 on alveolar epithelial barrier function, we initially measured TER. On day 4, prior to transduction, all alveolar epithelial cells had comparable TER, ϳ400 ⍀·cm 2 ( Fig. 2A) . However, by day 6, alveolar epithelial cells expressing YFP-Cldn-4 showed a significant increase in TER relative to untreated and control YFP-treated cells. Surprisingly, the TER of cells expressing YFP-Cldn-3 was significantly lower than that of untreated or control YFP-treated cells (Fig. 3A) , indicating that Cldn-3 induced a decrease in alveolar barrier function. Importantly, TER of untreated and control YFP-treated cells was comparable throughout the course of the experiment, demonstrating that the adenovector transduction did not alter alveolar barrier function.
We also determined that I sc measurements for alveolar epithelial monolayers were comparable to previously published values (25, 27) (Fig. 3B) . I sc was significantly higher for cells expressing YFP-Cldn-3 than for controls. By contrast, I sc was comparable in cells expressing YFP-Cldn-4 and control cells. While expression of YFP-Cldn-3 and YFP-Cldn-4 had different effects on I sc and TER, increased expression of these two claudins did not alter the relative charge specificity of alveolar epithelial tight junctions ( Fig. 3C ) P Na /P Cl of cells expressing YFP-Cldn-3 and YFP-Cldn-4 was comparable to that of control cells (P Na /P Cl ϳ1.1), reflecting a slight preference for Na over Cl permeability (7) . P Na /P Cl was comparable when dilution potentials were determined in the apical-to-basal direction, or vice versa (data not shown). This result is consistent with the high degree of homology between the first extracellular loop domain of Cldn-3 and Cldn-4 (15), which is responsible for claudin charge specificity (11) .
As another measure of alveolar barrier function, we examined paracellular permeability to two fluorescent aqueous tracers: a small molecule (0.62 kDa), calcein, and a macromolecule (10 kDa), Texas Red dextran (Fig. 4) . Cells expressing YFPCldn-3 showed significant increases in the paracellular permeability of both fluorescent dyes, a result that further supports a decreased barrier function in response to increased Cldn-3. In contrast, paracellular permeability to fluorescent dyes was comparable in cells expressing YFP-Cldn-4 or YFP alone and untreated control cells.
Given these findings, we performed a detailed analysis to determine how increasing Cldn-3 or Cldn-4 had affected other, endogenous tight junction proteins. Immunofluorescence microscopy analysis showed that the tight junction morphology of cells expressing YFP-Cldn-3 and YFP-Cldn-4 was comparable to that of control cells (Figs. 5 and 6 ), demonstrating that expression of these proteins was not deleterious to the cells. YFP-Cldn-3 and YFP-Cldn-4 colocalized with the other claudins, occludin, and ZO-1, consistent with previous results (8, 14, 48, 51) . Although YFP-Cldn-3 had little effect on the localization of endogenous Cldn-4 ( Fig. 5N) , in some areas, we found a more continuous distribution of endogenous Cldn-3 in cells expressing YFP-Cldn-4 along the plasma membrane (Fig.   5E ), rather than the more punctate appearance we observed in control cells (Fig. 5D) . The change in Cldn-3 induced by YFP-Cldn-4 suggests that, at a certain threshold, Cldn-4 can alter incorporation of Cldn-3 into tight junctions, most likely by a heteromeric interaction (15) . Consistent with images obtained by immunofluorescence microscopy (Fig. 6) , immunoblot analysis of YFP-Cldn-3 and YFP-Cldn-4 demonstrated comparable levels of several other tight junction proteins, Values are means Ϯ SE (n ϭ 6). *P Ͻ 0.05. Isc was comparable in cells expressing YFP-Cldn-4 and YFP alone on day 6. C: epithelial permeability to Na relative to Cl (PNa/PCl) was comparable in cells expressing YFP-Cldn-3 or YFP-Cldn-4 and YFP alone, reflecting a slight preference for Na over Cl permeability. Values are means Ϯ SE (n ϭ 6).
including Cldn-1, Cldn-5, Cldn-7, Cldn-18, occludin, ZO-1, and ZO-2, in whole cell lysates (Fig. 7) .
To address the possibility that the junction protein assembly might be affected by expression of YFP-Cldn-3 or YFPCldn-4, we used a biochemical assay in which proteins were extracted from cells using 0.5% Triton X-100. At this concentration of Triton X-100, the insoluble fraction primarily reflects proteins incorporated into tight junctions (43, 47) . Our rationale in using this approach was that a biochemical assay would allow us to detect changes in tight junction proteins that are undetectable at the level of indirect immunofluorescence microscopy. In untreated alveolar epithelial cells, tight junction proteins ranged from ϳ75% insoluble (ZO-1, ZO-2 occludin, and Cldn-18) to Ͻ20% insoluble (Cldn-5, Cldn-7, and Cldn-1; Fig. 8, A and B) . The cytosolic proteins ZO-1 and ZO-2 were the least soluble of the tight junction proteins, consistent with their role as scaffold proteins that cross-link transmembrane tight junctions to the cytoskeleton (22, 23, 47) . Cldn-18 was also significantly more insoluble than the other claudins. Importantly, the array of claudin solubility revealed a much broader range for alveolar epithelial claudins than has been previously demonstrated.
In keeping with our previous findings, endogenous Cldn-3 had intermediate Triton X-100 solubility, while Cldn-4 was mainly soluble (14) . Compared with endogenous Cldn-3 and Cldn-4, YFP-Cldn-3 and YFP-Cldn-4 had comparable solubility characteristics, consistent with the ability of these tagged claudins to properly associate with scaffold proteins [51.1 Ϯ 1.3% for YFP-Cldn-3 (n ϭ 4), 47.4 Ϯ 1.8% for Cldn-3 (n ϭ 3), 29.7 Ϯ 4.0% for YFP-Cldn-4 (n ϭ 3), and 34.3 Ϯ 4.3% for Cldn-4 (n ϭ 3)]. However, we found that that expression of YFP-Cldn-3 and YFP-Cldn-4 had differential effects on the solubility of other alveolar epithelial claudins (Fig. 8C) . Cells expressing YFP-Cldn-3 showed a significant increase in the pool of insoluble Cldn-5 compared with untreated control cells or cells expressing YFP-Cldn-4. By contrast, significantly less Cldn-7 was associated with the Triton X-100-insoluble pool in YFP-Cldn-4-than YFP-Cldn-3-expressing cells (Fig. 8C ). The Triton X-100 solubility of the other tight junction proteins was not affected by YFP-Cldn-3 or YFP-Cldn-4 expression (Fig. 8C) .
Taken together, these data suggest that the predominant effect of YFP-Cldn-3 and YFP-Cldn-4 on alveolar epithelial barrier function was due a specific increase in expression and utilization of Cldn-3 or Cldn-4 in tight junctions as opposed to a major effect of altering these claudins on expression or localization of other alveolar epithelial tight junction proteins.
DISCUSSION
In the uninjured lung, the alveolar epithelium acts as a barrier to fluid leak and regulates ion transport to promote fluid absorption from the alveolar space. The overall paracellular permeability characteristics of an epithelium are determined by the pattern of claudin expression. Several different claudins have been found to be expressed by alveolar epithelial cells; however, our understanding of the functional roles of specific individual claudins in the alveolar epithelium is incomplete.
Roles for two prominent lung claudins, Cldn-3 and Cldn-4, were defined using transduced cultured primary alveolar epithelial cells, enabling the function of these two claudins to be examined in the context of other alveolar epithelial claudins. We found that increasing expression of Cldn-3 or Cldn-4 in alveolar epithelial cells had different effects on paracellular permeability. Increased expression of Cldn-3 was associated with decreasing alveolar epithelial TER from ϳ550 to ϳ400 ⍀·cm 2 in our model type I cell system (Fig. 3) and also increased paracellular permeability to aqueous tracers up to 10 kDa (Fig. 4) . A role for Cldn-3 in decreasing alveolar barrier , further incubated for 2 days, and then fixed and analyzed by immunofluorescence microscopy for Cldn-7 (B, E), Cldn-18 (H, K) or ZO-1 (N, Q). As previously described (29) , distribution of Cldn-7 was more irregular than Cldn-18 or ZO-1, which exhibited a more uniform labeling of tight junctions. Induced expression of YFP-Cldn-3 or YFP-Cldn-4 had little effect on localization of these endogenous tight junction proteins. Scale bars, 10 m. function was also proposed by Chen et al. (8) , who found that alveolar tightening induced by epidermal growth factor in vitro was associated with decreased Cldn-3 expression.
By contrast, increased Cldn-4 expression increased TER, which is consistent with a role for this claudin in protecting the lung from acute injury (28). Wray et al. (51) used two independent methods to disrupt Cldn-4, the effects of which resulted in decreased epithelial TER. In addition, they found that increasing Cldn-4 expression using phorbol esters increased monolayer TER, although this approach is subject to other effects that occur when protein kinase C is activated (6, 52) . Here, we extended these observations by demonstrating that a direct increase in Cldn-4 expression was sufficient to increase alveolar epithelial cell TER. However, increasing Cldn-4 expression did not significantly alter paracellular permeability to aqueous fluorescent tracers by alveolar epithelial cells (Fig. 4) . Although changes in TER often parallel changes in paracellular permeability, this is not always the case, as demonstrated using cells expressing mutated claudins or occludin (5, 37) . Indeed, it has been proposed that dye flux assays are more a measure of tight junction remodeling/turnover than the instantaneous ion barrier properties that are reflected by TER measurements (39, 40) . Thus our results indicate that increasing total Cldn-4 had distinct effects on these two different aspects of the tight junction barrier.
The differential effects of increasing Cldn-3 and Cldn-4 are interesting in light of results demonstrating that in vitro treatment of mice with CPE BD has little effect on the unstressed lung; however, CPE BD dramatically increases pulmonary edema due to ventilator-induced lung injury (51) . Given that CPE BD interacts with Cldn-3 and Cldn-4 (35) and our results that show opposing effects of Cldn-3 and Cldn-4 on alveolar barrier function, in vivo application of CPE BD could have offsetting effects on these two claudins in the unstressed lung. However, during lung injury, when Cldn-4 is upregulated and essential for efficient fluid clearance (51), the effect of CPE BD on lung barrier function is much more apparent.
On the basis of amino acid homology, Cldn-3 and Cldn-4 are the two most closely related mammalian claudins. This homology between the two claudins is particularly high in the first extracellular loop domain, which is primarily responsible for regulating the charge specificity of tight junction permeability (4, 11, 44) . Although the first extracellular loops of Cldn-3 and Cldn-4 are 94% identical, a single amino acid residue alters the ability of Cldn-3 and Cldn-4 to heterotypically interact with claudins on adjacent cells (15) . While Cldn-3 can interact with several other claudins, including Cldn-1, Cldn-2, and Cldn-5, Cldn-4 has only been demonstrated to homotypically interact with itself (12, 15) . In contrast, the second extracellular loops of Cldn-3 and Cldn-4 are more divergent (64% identical). Given that the second extracellular loop has also been shown to influence assembly of claudins into tight junctions (15, 37, 38) , differences in this domain suggest that Cldn-3 and Cldn-4 would each have a differential influence on tight junction formation.
In addition to the extracellular loop domains, the cytoplasmic COOH terminus is the other major functional claudin domain (45) . While Cldn-3 and Cldn-4 have high homology in the first extracellular domain, they show considerably more divergence in the second extracellular loop domain and cytoplasmic COOH-terminal tail, both of which help regulate claudin assembly (10, 15, 38) . Although both of these claudins can interact with ZO-1 and ZO-2 (42, 47), Cldn-3 and Cldn-4 are likely to interact with unique scaffolding proteins (13) . In fact, claudin stability appears to be controlled by scaffold proteins other than ZO-1 and ZO-2, since removing the PDZ-binding motif has little effect on overall claudin half-life (45) . Whether claudins compete for a pool of scaffold proteins or whether specific combinations of claudins are corecruited by the tight junction scaffold remains largely unanswered.
Increased expression of a particular claudin by cells can have a dramatic effect on ion permeability or no effect, depending on the other claudins expressed by the cells (46) . This observation is significant, because while we observe a decrease in barrier function when Cldn-3 is increased in alveolar epithelial cells, recent evidence demonstrates that increased Cldn-3 augments barrier function of a low-resistance clone of Madin-Darby canine kidney epithelial cells as measured by TER and paracellular permeability to aqueous tracers (34) . However, in the case of Madin-Darby canine kidney cells, increasing Cldn-3 expression enabled an interaction with Cldn-2, which served to increase TER from ϳ50 to ϳ100 ⍀·cm 2 (34), whereas we observed a decrease from ϳ550 to ϳ400 ⍀·cm 2 (Fig. 2) . These results suggest that Cldn-3 may promote the sealing of low-resistance tight junctions while modulating the permeability of high-resistance tight junctions. However, it may be that the role of Cldn-3 is determined by cell-specific factors as opposed to a universal property of Cldn-3 itself.
Triton X-100 insolubility is frequently used as a measure for incorporation of proteins into tight junction strands (18, 36, 41, 50) . Interestingly, we found that claudins expressed by alveolar epithelial cells showed a range of Triton X-100 insolubility (Fig. 8) , ranging from highly insoluble (Cldn-18) to predominantly soluble (Cldn-1). The finding that alveolar epithelial claudins show differences implies that alveolar tight junctions have a heterogeneous molecular organization that can affect barrier function. Importantly, Triton X-100 solubility of YFP-Cldn-3 and YFP-Cldn-4 was comparable to that of their native counterparts, consistent with the tagged claudins being properly assembled into tight junctions. By and large, transducing cells with YFP-Cldn-3 or YFP-Cldn-4 had a limited effect on Triton X-100 insolubility of other tight junction proteins, although YFP-Cldn-3 induced an increase in Cldn-5 insolubility and YFP-Cldn-4 decreased Cldn-7 insolubility. Whether these changes have a direct impact on tight junction permeability remains to be determined. Given that increased Cldn-5 expression is associated with a decrease in alveolar barrier function (19, 48) , we speculate that increased incorporation of Cldn-5 into alveolar epithelial junctions may contribute to the ability of YFP-Cldn-3 to increase tight junction permeability.
Taken together, our results show that differential expression of Cldn-3 and Cldn-4 produced alveolar epithelial monolayers with unique paracellular permeability. By directly transducing primary alveolar epithelial cells, we were able to demonstrate that increased expression of Cldn-4 was sufficient to increase alveolar epithelial cell barrier function, while increased Cldn-3 had the opposite effect. Since type II alveolar epithelial cells in situ express significantly higher levels of Cldn-3 than type I cells (14, 24, 29, 31, 48) , we speculate that Cldn-3 plays a specialized role in regulating the permeability of cell junctions formed by type II cells, such as junctions between type II cells and type I cells. One potential implication of this model is that the alveolar barrier may be heterogeneous, particularly when type II-type I cell interfaces are compared with type I-type I cell interfaces. Determining whether type II-type I cell junctions are preferentially more permeable than type I-type I cell junctions is a future challenge that will require novel methods to measure permeability of individual alveolar tight junctions in situ.
